Targeting glial modulation: molecular mechanisms of Polygonatum in neurological disorders
- 1Chemistry and Biochemistry Laboratory, Guizhou Medical University , , ,
Abstract
Neurological disorders arise from interconnected pathological processes, including oxidative stress, neuroinflammation, mitochondrial dysfunction, impaired proteostasis, synaptic injury and blood brain barrier disruption. Increasing evidence indicates that glial cells are not passive bystanders in these diseases, but central regulators of neuroimmune balance, metabolic support, myelin integrity and tissue repair. Polygonatum spp., a traditional medicinal and edible plant, contains diverse bioactive constituents, including polysaccharides, steroidal saponins and flavonoids, which exhibit multi-target neuroprotective activities. In this Review, we summarize current evidence linking Polygonatum and its active compounds to the modulation of glial function and neuronal survival. Polygonatum polysaccharides appear to suppress microglial overactivation, attenuate TLR4/NF-κB and NLRP3 inflammatory signalling, restore redox homeostasis through NRF2-related pathways, and reduce lipid peroxidation and ferroptosis. In parallel, Polygonatum -derived compounds may support mitochondrial function, protein homeostasis, synaptic plasticity and neurotransmitter balance, thereby improving pathological outcomes in models of Alzheimer’s disease, Parkinson’s disease, cerebral ischaemia, depression and sleep disturbance. Evidence for direct effects on oligodendrocytes, astrocytes, oligodendrocyte precursor cells and the neurovascular unit remains limited but suggests an important area for future investigation. Standardized botanical sources, extraction procedures, pharmacokinetic analyses and high-quality clinical studies will be essential to define the therapeutic potential of Polygonatum-based interventions for neurological diseases.
Related
- Targeting Sirtuins in Neurodegenerative and Psychiatric Disorders: From Molecular Mechanisms to Pharmacological Modulation
- Targeting the microglia-synapse interface in depression: molecular mechanisms and pharmacological perspectives from traditional Chinese medicine
- Molecular Mechanisms of the Anticancer Activity of Hinokitiol in C32 Melanoma Cells: Transcriptomic Analysis and Modulation by a Static Magnetic Field
- Targeting neddylation in cancer: molecular mechanisms, translational advances, and therapeutic challenges
- Targeting oral cancer with curcumin and its structural analogs: molecular mechanisms, pharmacokinetic optimization, and clinical translation.
BibTeX
@article{liu2026targeting,
title = {{Targeting glial modulation: molecular mechanisms of Polygonatum in neurological disorders}},
author = {Zilong Liu and Yixun Luo and Chuanfeng Zheng and Xiuzhen Long and Yiqi Zhao and Zhiying Pan and Bingyang Xu and Jianfei Sun},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1969384},
url = {https://europepmc.org/article/PMC/PMC13669545},
note = {CC BY},
}
RIS
TY - JOUR
TI - Targeting glial modulation: molecular mechanisms of Polygonatum in neurological disorders
AU - Zilong Liu
AU - Yixun Luo
AU - Chuanfeng Zheng
AU - Xiuzhen Long
AU - Yiqi Zhao
AU - Zhiying Pan
AU - Bingyang Xu
AU - Jianfei Sun
PY - 2026
DA - 2026/10/01
JO - Frontiers in pharmacology
DO - 10.3389/fphar.2026.1969384
UR - https://europepmc.org/article/PMC/PMC13669545
AB - Neurological disorders arise from interconnected pathological processes, including oxidative stress, neuroinflammation, mitochondrial dysfunction, impaired proteostasis, synaptic injury and blood brain barrier disruption. Increasing evidence indicates that glial cells are not passive bystanders in these diseases, but central regulators of neuroimmune balance, metabolic support, myelin integrity and tissue repair. Polygonatum spp., a traditional medicinal and edible plant, contains diverse bioactive constituents, including polysaccharides, steroidal saponins and flavonoids, which exhibit multi-target neuroprotective activities. In this Review, we summarize current evidence linking Polygonatum and its active compounds to the modulation of glial function and neuronal survival. Polygonatum polysaccharides appear to suppress microglial overactivation, attenuate TLR4/NF-κB and NLRP3 inflammatory signalling, restore redox homeostasis through NRF2-related pathways, and reduce lipid peroxidation and ferroptosis. In parallel, Polygonatum -derived compounds may support mitochondrial function, protein homeostasis, synaptic plasticity and neurotransmitter balance, thereby improving pathological outcomes in models of Alzheimer’s disease, Parkinson’s disease, cerebral ischaemia, depression and sleep disturbance. Evidence for direct effects on oligodendrocytes, astrocytes, oligodendrocyte precursor cells and the neurovascular unit remains limited but suggests an important area for future investigation. Standardized botanical sources, extraction procedures, pharmacokinetic analyses and high-quality clinical studies will be essential to define the therapeutic potential of Polygonatum-based interventions for neurological diseases.
SN - 1663-9812
ER -